Searchable abstracts of presentations at key conferences in endocrinology

ea0020p396 | Diabetes and Cardiovascular | ECE2009

Diabetes and obesity associated difference in aggregation platelet capacity

Hlazkova Anastasiya , Yaroshevich Natalya , Romanovskiy Alieksey , Melnik Irina , Pishik Valentina

Diabetes mellitus and abdominal obesity are considered to be risk factors for venous and arterial thrombosis, but till now it still remains unclear, what factor is a primary in the genesis of these abnormalities: fibrinolysis dysfunction, vascular endothelium impairment or pathology of the platelet homeostasis component.Forty-two persons included in the study were primary divided into 3 groups: 1 group – nearly healthy (10 males, 12 females), 2 grou...

ea0022p786 | Thyroid | ECE2010

Effect of pentoxifylline and glucocorticoids on peripheral blood mononuclear cells proliferation and apoptosis in Graves' ophthalmopathy

Hlazkova Anastasiya , Melnik Irina , Danilova Larissa , Kosmacheva Svetlana , Goncharova Nataliya , Antipovich Denis , Kirilenko Janna

The phosphodiesterase inhibitor pentoxifylline (PTX) is known to have immunomodulatory effects in some autoimmune diseases. The aim of our study was to assess the influence of glucocorticoids monotherapy and additive treatment with PTX on peripheral blood mononuclear cells (PBMC) proliferation and apoptosis in patients with Graves’ ophthalmopathy (GO).Eighteen patients with GO and 28 healthy controls were investigated. GO patients were divided into ...

ea0020p61 | Thyroid | ECE2009

Influence of pentoxifylline on peripheral blood mononuclear cells proliferation and apoptosis in Graves’ ophthalmopathy

Melnik Irina , Hlazkova Anastasiya , Kosmacheva Svetlana , Goncharova Natallia , Danilova Larisa , Romanovskiy Aleksey

Pentoxifylline (PTX), a phosphodiesterase inhibitor, has a positive therapeutic effect in some autoimmune diseases due to immunomodulatory action.The aim of the study was to assess the influence of PTX on apoptosis and peripheral blood mononuclear cells (PBMC) proliferation in patients with Graves’ ophthalmopathy (GO).Twenty-four patients with GO and 32 healthy controls were investigated. GO patients were divided into two grou...